A Cleveland Clinic spinout company that has developed a “GPS-like” tool for minimally invasive surgeries says that the system worked well during its first animal trial.
Centerline Biomedical's system is designed to help surgeons move catheters and guidewires through the body without using X-ray fluoroscopy, which subjects patients to radiation.
During the trial, Centerline's Intra-Operative Positioning System “allowed for excellent accuracy in navigating through the arteries,” according to a news release from the company.
The study was led by Dr. Matthew Eagleton, a Cleveland Clinic surgeon who specializes in minimally invasive aortic surgery. In the release, he described the IOPS system as “a game-changer in the era of endovascular therapy.”
Founded in 2014, Centerline is led by Dr. Jai Gupta, chairman and CEO, and Dr. Vinod Goel, president.
“We are excited about reaching this important milestone as we launch our campaign for Series-A financing,” Goel stated in the release. “This study is an important step in taking us to our goal of FDA regulatory submission, with market entry targeted in the third quarter of 2017.”
"Cleveland Clinic spinout says surgery tool worked well during animal trial" originally appeared in Crain's Cleveland Business.
